Washington R.Phs. prescribing birth control in pilot project

Exkivity remains available while Takeda works with the FDA on withdrawal timing, and the company said that patients currently taking the therapy will continue to have access after it is withdrawn.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

The gut-brain-skin axis is more important to overall health than previously understood, and prebiotics and probiotics play a large role in the benefits.

Kevin is joined by Dr. Thea Blystone, PharmD for a talk about finding fulfillment and satisfaction in the pharmacy world, plus how to find balance between serving others and having time for yourself.

The NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.

Vaccines were tested against various strains of the SARS-CoV-2 virus.